Skip to main content

Table 2 Related metabolites that exist at abnormal levels in the exhaled air samples among carcinoma, gastric ulcer gastritis patients and normal controls

From: Volatile organic metabolites identify patients with gastric carcinoma, gastric ulcer, or gastritis and control patients

Potential biomarker

RT

Carcinoma vs normal

Carcinoma vs gastric ulcer

Carcinoma vs gastritis

P-value

FC

VIP

P-value

FC

VIP

P-value

FC

VIP

2,3-Butanediol, [R-(R*,R*)]-

3.09

2.49E−03

0.8

2.1885

      

1,3-Dioxolan-2-one

7.58

2.56E−03

− 1.04

2.0577

      

Hexadecane

18.36

1.04E−04

3.61

1.818

      

Undecane, 3,8-dimethyl-

18.36

1.30E−02

4.2

1.7379

      

N,N-Dimethylacetamide

5.55

   

8.34E−04

− 3.45

1.9534

3.52E−11

− 3.63

2.1254

Phosphonic acid, (p-hydroxyphenyl)-

8.07

   

3.01E−04

− 1.46

1.5537

4.54E−05

− 1.12

1.6612

1,3-Dioxolane-2-methanol

11.66

   

4.38E−04

3.56

1.5061

2.01E−03

0.98

1.7984

3,5-Decadien-7-yne, 6-t-butyl-2,2,9,9-tetramethyl-

18.94

      

9.02E−08

− 11.38

2.1523

1,6-Dioxacyclododecane-7,12-dione

19.71

      

3.05E−07

− 5.75

1.7882

Caprolactam

15.83

      

2.18E−06

− 4.92

1.7731

5,7-Octadien-2-one, 3-acetyl-

14.11

      

7.92E−06

− 9.83

1.6588

Nonanal

11.01

      

2.80E−06

− 1.54

1.6415

5-Hepten-2-one, 6-methyl-

8.08

      

5.02E−05

− 0.96

1.6318

Benzothiazole

13.62

      

9.42E−03

0.64

1.5273

  1. RT retention time, FC fold change, VIP variable importance in the projection